• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Emerald Health Therapeutics Gets Approval for New Organic Facility

    Bryan Mc Govern
    Jun. 24, 2019 08:51AM PST
    Cannabis Investing News

    Emerald Health Therapeutics secured a cultivation license for an organic cannabis facility in Vancouver, BC.

    Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) secured a cultivation license for an organic cannabis facility in Vancouver, BC.

    As quoted in the press release:

    Emerald Health Therapeutics has received its initial cultivation license from Health Canada for its new organic cannabis growing facility in Metro Vancouver, BC. Tailor-made for Emerald to produce high-quality organic cannabis, the operation comprises two 78,000 square foot greenhouses and 12 acres (~500,000 square feet) of outdoor cultivation, with potential for an additional 12 acres. This license permits cultivation in an initial 15,000 square feet of greenhouse area. This site was purposefully designed for organic cultivation with the goal to exceed 30,000 kilograms of annual production, assuming licensing of the entire indoor and outdoor production area.

    “Organic products appeal to many consumers, including many cannabis users, and we look forward to serving both medical and recreational consumers with our quality organic cannabis products,” said Dr. Avtar Dhillon, Executive Chairman and President of Emerald.

    Construction of the first greenhouse is complete; the second greenhouse is expected to be completed in Q4; and the first 12 acres of outdoor area is ready for planting. Production at the facility is subject to obtaining necessary municipal approvals, which Emerald is working to complete.

    Click here to read the full press release.

    cannabis investingtsxv:emhcanadaemerald health therapeuticsavtar dhillon
    The Conversation (0)

    Go Deeper

    AI Powered
    Cannabis Investing

    Cannabis Weekly Round-Up: Mexico Ready to Legalize Cannabis-Based Products

    business meeting evaluating financial results

    Cannabis Weekly Round-Up: Organigram Results Improve, Ascend Ready for Lawsuit

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×